Moderators: S. Karagiannis (UK), E. Gkika (DE)
19.00-19.20 GR (18.00-18.20 CET) Chemotherapy & the new Tumor microenvironment G. Karagiannis (US)
Q&A
19.25-19.45 GR (18.25-18.45 CET) IgE class antibodies to activate anti-cancer immune surveillance S. Karagiannis (UK)
Q&A
19.50-20.10 GR (18.50-19.10 CET) The Tumor microenvironment and response to immunotherapy P. Foukas (GR)
Q&A
Moderators: S. Karagiannis (UK), E. Gkika (DE)
20.15-20.35 GR (19.15-19.35 CET) Modulation of the tumor microenvironment using radiotherapy M. Koukourakis (GR)
Q&A
20.40-21.00 GR (19.40-20.00 CET) Time Radiotherapy and immunotherapy combinations. Lessons learned so far E. Gkika (DE)
Q&A
